(1)
Amin Shahrbaf, M.; Samimi, M.; Karimi, S.; Salari, M.; Ghaffari, M.; Yazdanbakhsh, S.; Najafian, A.; Vosough, M.; Massood Nabavi, S. The First Study of Real-World Efficacy and Safety of Natalizumab (Tysabri®) in Iran. Trends Immunother. 2024, 8.